Suppliers / Pt. Novell Pharmaceutical Laboratories

Pt. Novell Pharmaceutical Laboratories

Indonesia Updated 9 July 2026

Pt. Novell Pharmaceutical Laboratories is a finished-dose manufacturer based in Indonesia. It appears in 69 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), NPRA (MY) and EDE (AE). Its GMP standing is certified by BPOM (ID) and EMA. Customs aggregates show $2.8M of exports covering 157 molecules to 23 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants
69
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Bogor, United Arab Emirates Not on file
Bogor, United Arab Emirates Not on file
Gunung Putri, Indonesia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 50 None
NPRA (MY) 11 None
EDE (AE) 5 None
SFDA (Saudi Arabia) 3 None
BPOM (ID) None 42
EMA None 3

Scale

Year Revenue Exports Destinations
2025 Not reported $2.8M 23
2024 Not reported $6.1M 28

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Pt. Novell Pharmaceutical Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts